Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Stock to buy today: Aurobindo Pharma (₹1,296.20)
The stock of Aurobindo Pharma appreciated 5.3 per cent last week. Consequently, it has broken out of a key resistance at ₹1,240, a bullish signal. While ₹1,325 is a minor hurdle, this can only lead to a corrective decline because the…
Stock Market Live Updates Mar 16: Stock to buy today: Aurobindo Pharma (₹1,296.20)
Stock Market Today | Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 16 March 2026 The stock of Aurobindo Pharma appreciated 5.3 per cent last week.
Ozempic Patent Expiry Heralds Weight-Loss Drug Boom in India
Swati Pradhan sees about 12 obesity patients a day at her small clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S 's blockbuster…
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) saw a large decrease in short interest during the month of February. As of February 27th, there was short interest totaling 99,192 shares, a decrease of 21.0% from the February 12th…
Dorsey Asset Management LLC Buys Shares of 2,350,449 Royalty Pharma PLC $RPRX
Dorsey Asset Management LLC purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional…
Lupin taking bigger bets on innovation, more proprietary products in India: Lupin MD
Drugmaker Lupin is taking big bets on innovation and will present “a very different story by even as early as next year,” said Nilesh Gupta, Lupin Managing Director. “This is a pivot year for India...the articulation that…
PGIM Jennison Health Sciences Fund Q4 2025 Commentary (PHLAX)
Strong stock selection in biotechnology, pharmaceuticals, and medtech, plus underweights in healthcare providers and medtech, contributed most to relative outperformance. LLY's robust launches of Mounjaro and Zepbound, regulatory derisking, and…
Finding a niche in air, water and carbon
It's rather apt that one meets veteran entrepreneur Deepak Pahwa on a day when Delhi's air quality is particularly bad. His Pahwa group of companies, which include the over 60-year-old Bry-Air, Desiccant Rotors International (DRI), DelAir and…
Growth Stocks To Follow Today - March 15th
3 Under-the-Radar AI Infrastructure Stocks Powering the Next Buildout Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of…
24 stocks in focus today: JSW Steel, Adani Power, Hindalco, RailTel, Waaree Energies, BCCL, Fino Payments, Jubilant Ingrevia, VA Tech, and Bajel Projects
The Contract Finalisation Department of Bharat Coking Coal Limited has approved the termination of the contract agreement with Loyabad Coalfields Private Limited for the “Re-opening, Development & Operation of Loyabad Coal Mine on Revenue…
Sasha Latypova in Dutch Case: Covid Injections Like 'ASSAULT WITH A WEAPON'
Exposing The Darkness is a reader-supported publication. To support my work, please consider becoming a paid subscriber. One-time or recurring donations can be made through Ko-Fi: ⚡ What aren't they telling you? Please Join Exposing the…
Mineralys Therapeutics (NASDAQ:MLYS) Upgraded to Hold at Wall Street Zen
Mineralys Therapeutics (NASDAQ:MLYS - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a note issued to investors on Sunday. There's a Lot to Love About Mineralys' Valentine's Day…
5 Most Disturbing Black Mirror Episodes
This article contains mentions of several unsettling topics. Netflix's Black Mirror is often scary and unsettling, as it introduces its audiences to the world of futuristic technology. With every episode featuring new characters and an entirely…
Fortrea Holdings Inc. (NASDAQ:FTRE) Given Average Rating of 'Hold' by Brokerages
Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) has earned an average rating of 'Hold' from the eleven analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell…
Alliant Energy Corporation $LNT Shares Bought by Aventail Capital Group LP
Aventail Capital Group LP grew its holdings in Alliant Energy Corporation (NASDAQ:LNT - Free Report) by 261.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The…
Receive a Daily briefing on Pharma Industry News
Get Started